Pendium

Step 1 of 8

Theralogix owns the specialist supplement conversation, but mass-market competitors are winning the broad wellness prompts.

Your clinical reputation is a massive advantage that current AI models recognize, but there is a clear gap in visibility for your non-fertility product lines.

Theralogix's baseline score
64/100
GoodCatalog connected · 53 products

Theralogix has a commanding lead in specialized medical niches like PCOS management and fertility, where it is frequently cited as a top-tier recommendation. However, its visibility drops significantly in broader nutritional categories where more mainstream lifestyle brands like Thorne or Ritual dominate.

What we see
  • Ovasitol has exceptional 'reputational equity' in training data, appearing in thousands of organic community discussions.
  • The brand lacks significant editorial presence in general lifestyle publications (e.g., Wirecutter, Strategist), which hurts visibility in broad 'best multivitamin' prompts.
  • AI Overviews heavily favor Theralogix for technical urology terms where the site's clinical blog content ranks well.
  • Claude is notably more hesitant to recommend the brand for general health, preferring more 'household name' brands like Thorne unless specific conditions are mentioned.
  • Competitor Uqora is currently winning more 'alternative to' prompts in the UTI space due to higher brand-name search volume.
Business goals Theralogix is likely trying to hit
  • Expand dominance in the PCOS management category beyond Ovasitol
  • Increase direct-to-consumer sales for urology and kidney health lines
  • Capture more market share in the premium prenatal and fertility space
  • Leverage physician-referral trust to win generic search queries for NSF-certified vitamins